[Agranulocytosis and intravenous cloxacillin].
Two patients receiving parenteral cloxacillin treatment developed agranulocytosis. Upon discontinuation of the drug, the number of leukocytes rapidly returned to normal. It is likely that an immunologic mechanism may be implicated in this drug-induced blood dyscrasia.
D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D001170:Arthritis, Infectious / Q000188:drug therapy; D003023:Cloxacillin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009220:Myositis / Q000188:drug therapy; D010068:Oxacillin / Q000627:therapeutic use; D013211:Staphylococcus aureus / Q000302:isolation & purification
D003023:Cloxacillin; D010068:Oxacillin
Agranulocytose et cloxacilline intraveineuse.